4 days ago
SolV Independent Insurance Associates Announces Commitments to Help Employer Plans Amid Trump's New Drug Pricing Executive Order
Granite Bay, California, United States, May 30, 2025 -- SolV CEO Scott Kelley urges proactive planning as policy targets global price alignment
SolV Independent Insurance Associates today announced its plans and commitments for guiding employers through prescription drug cost management in light of the new 'most-favored-nation' executive order signed May 12 by President Donald J. Trump. As the order drives U.S. reimbursement rates toward international benchmarks, SolV is doubling down on its proven approach to help clients achieve significant savings and clarity amid evolving policy.
'SolV has long educated employers about the disparity between U.S. drug prices and those abroad,' said Scott Kelley, CEO of SolV Independent Insurance Associates. 'With U.S. prescriptions costing two to four times more than in other countries, employers need an advocate focused on reducing their largest expenses—not another middleman.'
SolV founder and CEO Scott Kelley noted that the new federal policy mirrors the firm's long-standing philosophy.
'A key linchpin to the Trump executive order is requiring pharmaceutical companies to honor international pricing for U.S. drug purchases,' Kelley said. 'U.S. prescription drugs cost two to four times more than drugs purchased internationally, according to a March 2021 GAO report. SolV has been helping clients tap into international pricing on drugs for years. That's why it's important to have the right benefits consultant—someone focused on curbing one of your largest expenses, not adding another middleman to your drug spend.'
While the executive order signals a shift toward greater cost containment, Kelley warns that the path forward will raise complex questions for employers:
'We welcome any attempt to rein in rising healthcare costs,' he said. 'But until policies are fully understood and implemented, employers are left grappling with how these changes affect their benefit strategies. That's where we come in—translating complex policy changes into actionable solutions.'
SolV is doubling down on four core service areas to guide clients through this transition:
'Any move that shines a light on America's broken prescription pricing system is a step forward,' he said. 'Until real savings materialize, we'll stay focused on what matters most: helping employers navigate these changes effectively.'
SolV will continue to monitor updates to the executive order and provide timely, personalized guidance as the healthcare landscape evolves.
About the company: SolV Independent Insurance Associates is a full-service employee benefits consulting firm founded by CEO Scott H. Kelley in 2016. With offices and representatives in California, Washington, Idaho, North Carolina, Arizona, and New York, SolV supports employers across the U.S. and internationally with expert guidance on employee benefits strategy, compliance, and cost management.
Scott Kelley is a Certified Employee Benefits Specialist (CEBS), a designation held by fewer than 2% of employee benefits consultants in the country. For more information, visit
Contact Info:
Name: Tess Dumlao
Email: Send Email
Organization: Phoenix PR & Marketing
Website:
Release ID: 89161087
If you come across any problems, discrepancies, or concerns related to the content contained within this press release that necessitate action or if a press release requires takedown, we strongly encourage you to reach out without delay by contacting [email protected] (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our committed team will be readily accessible round-the-clock to address your concerns within 8 hours and take appropriate actions to rectify identified issues or support with press release removals. Ensuring accurate and reliable information remains our unwavering commitment.
